Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07102251
What this trial is testing

Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects

Who this might be right for
Healthy Subjects
Sunshine Lake Pharma Co., Ltd. 126
Early research (Phase 1)Looking for participantsNCT07201558
What this trial is testing

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Who this might be right for
Rheumatoid ArthritisSystemic Lupus Erythematosus
AstraZeneca 48
Early research (Phase 1)Study completedNCT00916110
What this trial is testing

Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects

Who this might be right for
Healthy
Ablynx, a Sanofi company 72
Early research (Phase 1)Study completedNCT02623868
What this trial is testing

Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.

Who this might be right for
Dyslipidemia
Chong Kun Dang Pharmaceutical 30
Early research (Phase 1)Study completedNCT01156779
What this trial is testing

Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects

Who this might be right for
Diabetes Mellitus
Dong-A Pharmaceutical Co., Ltd. 31
Testing effectiveness (Phase 2)Study completedNCT02808585
What this trial is testing

Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF

Who this might be right for
Heart Failure
PhaseBio Pharmaceuticals Inc. 29
Early research (Phase 1)Study completedNCT01023321
What this trial is testing

First-in-Human Single Ascending and Multiple Dose of GLPG0555

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05387837
What this trial is testing

Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Ashvattha Therapeutics, Inc. 50
Early research (Phase 1)Study completedNCT06308861
What this trial is testing

Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males

Who this might be right for
Non-alcoholic Steatohepatitis
J2H Biotech 100
Early research (Phase 1)Study completedNCT00868595
What this trial is testing

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate Cancer (CRPC)
Bellicum Pharmaceuticals 18
Early research (Phase 1)Study completedNCT00356642
What this trial is testing

Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 45
Early research (Phase 1)Study completedNCT06160401
What this trial is testing

Evaluation of Safety, Tolerability, PK/PD, and Metabolism of Single-Dose Singletine(DC407) in Adults

Who this might be right for
Healthy Subjects
Guangzhou JOYO Pharma Co., Ltd 75
Early research (Phase 1)Study completedNCT02819726
What this trial is testing

PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Archigen Biotech Limited 294
Early research (Phase 1)Looking for participantsNCT06086522
What this trial is testing

Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Qualigen Theraputics, Inc. 54
Early research (Phase 1)Study completedNCT01119781
What this trial is testing

A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers

Who this might be right for
HealthyRenal Insufficiency
Biogen 35
Early research (Phase 1)Study completedNCT03585322
What this trial is testing

APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Ascentage Pharma Group Inc. 49
Testing effectiveness (Phase 2)Ended earlyNCT03330457
What this trial is testing

A Healthy Volunteer PK/PD, Safety and Tolerability Study of Andexanet After Betrixaban Dosing

Who this might be right for
Bleeding
Portola Pharmaceuticals 18
Early research (Phase 1)Study completedNCT04727138
What this trial is testing

3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546

Who this might be right for
Oncology
Exscientia AI Limited 64
Early research (Phase 1)UnknownNCT03120273
What this trial is testing

A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults（Part 2）

Who this might be right for
Effect of DrugsSafety Issues
First Affiliated Hospital of Zhejiang University 70
Early research (Phase 1)Not Yet RecruitingNCT07406438
What this trial is testing

To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Shenzhen Kexing Pharmaceutical Co., Ltd. 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation